Combination Therapy in Pulmonary Arterial Hypertension

被引：9
|
作者：
Channick, Richard N. [1 ]
机构：
[1] Harvard Univ, Massachusetts Gen Hosp, Sch Med,Dept Med, Pulm Hypertens & Thromboendarterect Program, Boston, MA USA
来源：
AMERICAN JOURNAL OF CARDIOLOGY | 2013年 / 111卷 / 08期
关键词：
CONTINUOUS INTRAVENOUS EPOPROSTENOL; SMOOTH-MUSCLE-CELLS; INHALED ILOPROST; BOSENTAN THERAPY; ORAL SILDENAFIL; EFFICACY; TREPROSTINIL; SURVIVAL; TRIAL; PROSTACYCLIN;
D O I：
10.1016/j.amjcard.2013.01.320
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Many potential therapeutic options are now available for patients with pulmonary arterial hypertension. Interest has emerged in using therapies in various combinations. Retrospective experience has suggested that this approach is common and can be efficacious. Data are emerging supporting the benefit of combination therapy; however, limitations and questions remain about this strategy. This report reviewed the rationale for combination therapy and summarized the results from clinical trials. (C) 2013 Elsevier Inc. All rights reserved. (Am J Cardiol 2013;111[suppl]:16C-20C)
引用
收藏
页码：16C / 20C
页数：5
相关论文
共 50 条
  • [11] Combination Therapy with Sildenafil and Sitaxentan for Pulmonary Arterial Hypertension
    Voswinckel, R.
    Gross, N.
    Reichenberger, F.
    Thamm, M.
    Karadas, B.
    Gall, H.
    Nef, H.
    Grimminger, F.
    Seeger, W.
    Ghofrani, H. A.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [12] The role of combination therapy in managing pulmonary arterial hypertension
    Ghofrani, Hossein-Ardeschir
    Humbert, Marc
    [J]. EUROPEAN RESPIRATORY REVIEW, 2014, 23 (134): : 469 - 475
  • [13] Combination Therapy with Rapamycin and Imatinib in Pulmonary Arterial Hypertension
    Shi, Y.
    Desai, A. A.
    Tang, H.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [14] The evolving landscape of combination therapy for pulmonary arterial hypertension
    Griffin, Matthew
    Trow, Terence K.
    [J]. THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2017, 11 (02) : 91 - 95
  • [15] Pulmonary arterial Hypertension: Initial Combination Therapy preferred
    不详
    [J]. KARDIOLOGE, 2020, 14 (01): : 2 - 2
  • [16] Role of Combination Therapy in the Treatment of Pulmonary Arterial Hypertension
    Abraham, Teena
    Wu, Gary
    Vastey, Fabienne
    Rapp, Jonathan
    Saad, Nasser
    Balmir, Eric
    [J]. PHARMACOTHERAPY, 2010, 30 (04): : 390 - 404
  • [17] Combination therapy for scleroderma associated pulmonary arterial hypertension
    Kabunga, P.
    Bloore, D.
    Das, C.
    Handler, C.
    Vrapi, F.
    Denton, C.
    Black, C.
    Smith, C.
    Coghlan, J.
    [J]. HEART, 2007, 93 : A101 - A102
  • [18] Sequential Combination Therapy in a Patient With Idiopathic Pulmonary Arterial Hypertension
    Tsareva, N. A.
    Avdeev, S. N.
    Neklyudova, G. V.
    [J]. KARDIOLOGIYA, 2016, 56 (03) : 97 - 100
  • [19] Combination therapy and new types of agents for pulmonary arterial hypertension
    O'Callaghan, Dermot
    Gaine, Sean P.
    [J]. CLINICS IN CHEST MEDICINE, 2007, 28 (01) : 169 - +
  • [20] Combination Therapy in Pulmonary Arterial Hypertension: Is This the New Standard of Care?
    Ruiz, George
    Besinque, Gary M.
    Lickert, Cassandra A.
    Raspa, Susan
    [J]. AMERICAN JOURNAL OF MANAGED CARE, 2015, 21 (08): : S151 - S161
12345